惯性聚合 高效追踪和阅读你感兴趣的博客、新闻、科技资讯
阅读原文 在惯性聚合中打开

推荐订阅源

云风的 BLOG
云风的 BLOG
钛媒体:引领未来商业与生活新知
钛媒体:引领未来商业与生活新知
J
Java Code Geeks
freeCodeCamp Programming Tutorials: Python, JavaScript, Git & More
Engineering at Meta
Engineering at Meta
OSCHINA 社区最新新闻
OSCHINA 社区最新新闻
小众软件
小众软件
博客园 - 聂微东
酷 壳 – CoolShell
酷 壳 – CoolShell
月光博客
月光博客
Last Week in AI
Last Week in AI
博客园_首页
I
InfoQ
T
Tailwind CSS Blog
爱范儿
爱范儿
雷峰网
雷峰网
Recent Announcements
Recent Announcements
F
Fortinet All Blogs
B
Blog
WordPress大学
WordPress大学
A
About on SuperTechFans
V
Visual Studio Blog
有赞技术团队
有赞技术团队
P
Proofpoint News Feed

All Articles on Seeking Alpha

All Eyes On Cencora, A Healthcare Supplier That Could See Lots More Upside Simply Good Foods Doesn't Look Like A Growth Stock Anymore Applied Digital: Post-Earnings Clarity Confirms An Accelerated Path To $1 Billion NOI Target IBIT: Why I Stepped To The Side (Technical Analysis) (Rating Downgrade) XES: Oil Service Stocks Turn Pricey; Why It's Time To Take Profits (Rating Downgrade) The Only Dividend Strategy I'd Trust In A 3.5% Fed Funds World Opera: AI-Driven Advertising Prospects - Upside Potential And Rich Dividend Yields RenaissanceRe: Preferred Stock Hasn't Been This Appealing In Years Q1 Earnings Kick Off With Major Banks' Results: Bank of America, Netflix In Focus Sezzle: Consolidation Completed, Re-Rating Ahead Bitmine Immersion Q2 Preview: Ethereum Thesis Facing Important Report Card I Am Sharing 2 Of My Retirement High-Yield Gems The Software Narrative Is Leaking Badly Again Thanks To Anthropic Mythos The Muni Market Looks Appealing In Q2 AVIV: Should Keep Rising If The Ceasefire Holds Foundayo Explained: Lilly's New Weight Loss Pill And The Amazon Effect Sabesp: A New Privatization As An Opportunity! EchoStar: Potential Bull Trap At Play - Take Gains Off The Table Teladoc Health: Improving Fundamentals Support A Turnaround Story March CPI Inflation: 5 Reasons To Stay Calm Two 12%+ Yielding BDC Bargains (One Is My Top Deep-Value Pick) TechnipFMC: We Prefer Saipem With More Room To Improve Tesla: From Bye-Bye To Buy-Buy (Rating Upgrade) DMB: Vulnerable To High Interest Rates Western Midstream: A 9% Yield That Still Grows In A Downturn IQQQ: Tax-Efficient Income From The Nasdaq But Does Not Protect Against Declines Qualys Share Price Pulled Down By Potential Cybersecurity Disruptor S&P 500: A Dead Money Era May Be Here. How To Thrive In It Vistance Networks Looks Better Than Before With Powerful Earnings Growth Commerce Bancshares: Valuation, Not Quality, Is The Problem
Inspire Medical Systems, Inc. (INSP) Presents at Bank of ...
2026-05-14 · via All Articles on Seeking Alpha

Inspire Medical Systems, Inc. (INSP) Bank of America Global Healthcare Conference 2026 May 13, 2026 11:00 AM EDT

Company Participants

Matthew Osberg - Executive VP & CFO
Timothy Herbert - Founder, Chairman, CEO & President
Ezgi Yagci - Vice President of Investor Relations

Conference Call Participants

Travis Steed - BofA Securities, Research Division

Presentation

Travis Steed
BofA Securities, Research Division

[Audio Gap]

Conference.

Question-and-Answer Session

Travis Steed
BofA Securities, Research Division

And we'll start out with you and, kind of, new CFO at Inspire. And how should we think about kind of the guidance setting strategy and kind of your handle on the CFO at Inspire.

Matthew Osberg
Executive VP & CFO

Yes. Yes. Well, first of all, thanks for hosting me. It's a great conference. Glad to be here. Thanks, everyone, for attending this morning. I'm excited to be with the company. Obviously, we're in a period of transition right now. But with the kind of market, the kind of product we have, what we do, very excited about the future. One of the things that as we've gone through this more current trend of top line challenge is I've been able to come in and help us really focus on some of our cost discipline and not necessarily how much we're spending, but what we're spending on and do a lot of prioritization.

We want to continue to recognize the top line situation we're in this year, but we're still investing for the future. We're still investing in revenue growth. We're still investing in product development. And I think there's lots of opportunities for us to continue to get more profitable. And as we move through this kind of transient period of reimbursement challenge, get back into strong growth, we're going to be able to come out of this kind of leaner and meaner and be